Johnson & Johnson
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
878 / 1328
Position in country
9359 / 14179
Return on Assets, %
7.4
-2.7
Net income margin, %
19.3
2.8
EBITDA margin, %
31.1
10.8
Debt to Equity, %
42.6
19.2
Intangible assets and goodwill, %
42.2
3.6
Revenue CAGR 3Y, %
1
8.5
Total Equity change 1Y, %
-10.5
0
Revenue Y, % chg
6.4
0.5
P/E
27.9
22.7
P/BV
5.1
1.5
P/S
4.1
2.3
EV/S
4.2
2.4
EV/EBITDA
11.7
7.4
Average Analyst recommendation
Hold
Hold
Average upside forecasts, %
18.6
51.3
Forward P/E
13.7
15.6
Dividend Yield, %
3.2
1.7
Forward Dividend Yield, %
3.3
0.2
Expected dividend per share
4.9
0
Payout Ratio, %
88.3
30.3
Dividend Ex Date
2024-02-16
Competitors
Ranks
-
Royalty Pharma PLC
00%
-
Zoetis Inc
00%
-
Eli Lilly and Co
00%
-
Bristol-Myers Squibb Co
00%
-
Elanco Animal Health Inc
00%
-
Johnson & Johnson
00%
-
Viatris Inc
00%
-
Merck & Co Inc
00%
-
Pfizer Inc
00%
-
Catalent Inc
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
United States of America
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Pharmaceuticals
Sub-sector
Health Care
Capitalization (millions of $)
355491.1
Ticker
JNJ.N
ISIN
US4781601046
IPO date
1944-09-25
Availability on Russian exchanges
Yes
Reporting for
2024-02-16
Date fact. publication of reports
2023-12-31
Company Description
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: